David S. Small

A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formation

John T. Brandt, Christopher D. Payne, Stephen D. Wiviott et al. · American Heart Journal · 2006 · 568 citations

Thrombopoiesis, Thrombosis, Clopidogrel Loading Doses +12

Effects of the Proton Pump Inhibitor Lansoprazole on the Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel

David S. Small, Nagy A. Farid, Christopher D. Payne et al. · The Journal of Clinical Pharmacology · 2008 · 315 citations

Thrombopoiesis, Molecular Pharmacology, Thrombosis +15

Increased Active Metabolite Formation Explains the Greater Platelet Inhibition With Prasugrel Compared to High-dose Clopidogrel

Christopher D. Payne, Ying Grace Li, David S. Small et al. · Journal of Cardiovascular Pharmacology · 2007 · 167 citations

Safety, Pharmacokinetics, and Pharmacodynamics of Drotrecogin Alfa (Activated) in Children With Severe Sepsis

Phil Barton, André C. Kalil, Simon Nadel et al. · PEDIATRICS · 2004 · 125 citations

Pharmacokinetic‐pharmacodynamic analysis of drotrecogin alfa (activated) in patients with severe sepsis

William L. Macias, Jean-François Dhainaut, Sau Chi Betty Yan et al. · Clinical Pharmacology & Therapeutics · 2002 · 98 citations